US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
read moreCelsense posts new whitepaper providing guidance to IND sponsors
Celsense posts new whitepaper providing guidance to IND sponsors
Publication in Journal for ImmunoTherapy in Cancer Highlights Fluorine 19 MRI Cell Tracking
Publication in Journal for ImmunoTherapy in Cancer Highlights Fluorine 19 MRI Cell Tracking
Press Release – The US National Institutes of Health Awards Grant to Celsense, Inc. to Fund Novel Product Development
The US National Institutes of Health Awards Grant to Celsense, Inc. to Fund Novel Product Development
Continue Exploring
Products
Papers
Real-Time Results,<br />Faster and More Accurate
Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
GET IN TOUCH
Send Us A Message
© 2018 Celsense, Inc. All rights reserved.